Inequitable Conduct Ripe For Review, Attys Say

Law360, New York (May 7, 2010, 6:16 PM EDT) -- Whether transformative or restorative, the U.S. Court of Appeals for the Federal Circuit’s en banc review of the inequitable conduct doctrine promises to bring some long-awaited clarity to the standards for proving deceit at the U.S. Patent and Trademark Office, according to legal experts.

On April 26, the Federal Circuit granted Abbott Laboratories’ an en banc rehearing in its protracted infringement action against Becton Dickinson & Co., setting the stage for Abbott to argue that its patent for a blood glucose test was wrongly nullified for...
To view the full article, register now.